Introduction

Hypertension is a major risk factor that leads to myocardial infarction, stroke, renal failure, and death1,2. Obesity raises the risk of morbidity from hypertension, dyslipidemia, diabetes, coronary heart disease (CHD), stroke and heart failure3,4,5,6. Hypertension and obesity are both associated with increased risks of all-cause and cardiovascular mortality7,8,9, and they often occur together10. Socioeconomic and demographic transitions occurring in many develo** countries have contributed to the burden of hypertension and obesity2,11, and the transition of morbidity from communicable diseases to non-communicable diseases12,13. With the rapid industrialization and urbanization seen in recent decades, the prevalence of hypertension and obesity has increased significantly in China, with the prevalence of obesity increased from 4.0% in 2002 to 10.7% in 200954,55,56, and a higher UA level has been associated with an increased risk of hypertension57,58. In addition, we found that the prevalence of high LDL-C was higher in obesity-related hypertensive patients. Compared to the non-obesity-related hypertensive patients, regular screenings for cardiovascular metabolic risk factors in obesity-related hypertensive patients should be advocated.

The strengths of this study include a large number of community-dwelling participants included in this survey and a detailed report of hypertension and obesity-related hypertension based on the 2017 ACC Guidelines in Southwest China. Our study has several limitations. First, this study was a cross-sectional study, meaning that the findings cannot be used to establish a conclusive cause-and-effect relationship between risk factors and obesity-related hypertension. Second, the participants were recruited from Southwest China, such that the conclusions cannot represent the situation in other regions of China. Third, we did not perform detailed body composition analysis due to constraints of budgets.

Conclusions

The prevalence of obesity-related hypertension was high in people aged 40 to 79 years in Southwest China. Its prevalence was higher in women than in men and increased with age. Additionally, patients with obesity-related hypertension had a higher prevalence of DM, hypertriglyceridemia, high low-density lipoprotein cholesterolemia and hyperuricemia than non-obesity-related hypertensive patients. Aggressive strategies aiming at the prevention and treatment of obesity-related hypertension are needed.